Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial update evaluating insulin efficacy and safety in patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 Diabetes [Phase 4]
A Phase 4 trial evaluating QR-Bromocriptine as an adjunct to insulin and metformin in type 2 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment [Phase 1]
Phase 1 feasibility study of DermGEN for diabetic foot ulcer treatment has completed with results posted.
-
FDA approval · 2019-09-13FDA Approved: COLESEVELAM HYDROCHLORIDE — Original Application (Bionpharma Inc.)
FDA approved a generic version of colesevelam hydrochloride (Colesevelam HCl) by Bionpharma Inc. under an original ANDA, for lipid-lowering …
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Using Peer Mentors to Support PACT Team Efforts to Improve Diabetes Control [NA]
Completed clinical trial assessing peer mentor support to improve diabetes control in type 2 diabetes patients; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients [Phase 4]
A Phase 4 clinical trial comparing glargine plus glulisine with premixed insulin in patients with type 2 diabetes has been completed.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: The Set-Point Study for Type 2 Diabetes: Evaluating the Use of an Insulin Only Bionic Pancreas System in Type 2 Diabetes [NA]
A completed clinical trial evaluating an insulin-only bionic pancreas system for Type 2 diabetes, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Preventing Microalbuminuria in Type 2 Diabetes [Phase 3]
Phase 3 clinical trial update focusing on preventing microalbuminuria in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 post-marketing trial update for KAD-1229 in type 2 diabetes mellitus has completed with results posted.
-
FDA approval · 2019-09-05FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for metformin hydrochloride, authorizing a generic version of metformin hydroch…
-
CLINICAL_TRIALS trial_result · 2019-09-03Clinical Trial Update: Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial evaluating the effect of dapagliflozin on nighttime blood pressure in individuals with type 2 diabetes.
-
CLINICAL_TRIALS research · 2019-08-30Clinical Trial Update: Exercise Training Improves Coronary Endothelial Dysfunction in Diabetes Mellitus Type 2 and Coronary Artery Disease [Phase 4]
Phase 4 trial update showing exercise training improves coronary endothelial dysfunction in patients with type 2 diabetes and coronary arter…
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus [Phase 4]
Phase 4 clinical trial update for a Type 2 diabetes mellitus study sponsored by AstraZeneca; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial compares semaglutide to liraglutide in adults with type 2 diabetes; results were completed and posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure [Phase 2]
A Phase 2 dose-finding trial evaluating LIK066 versus placebo or empagliflozin in patients with type 2 diabetes mellitus and heart failure h…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China
A completed clinical trial evaluating characteristics, treatment patterns, and target attainment of type 2 diabetes mellitus in older Chines…
-
FDA approval · 2019-08-28FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (PuraCap Laboratories LLC dba Blu Pharmaceuticals)
FDA approved a supplemental application for metformin hydrochloride (generic) submitted by PuraCap Laboratories LLC dba Blu Pharmaceuticals.
-
CLINICAL_TRIALS research · 2019-08-28Clinical Trial Update: Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes [Phase 4]
Clinical trial comparing exenatide with insulin glargine to assess changes in liver fat content in adults with type 2 diabetes and non-alcoh…
-
FDA approval · 2019-08-27FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Metformin Hydrochloride from Amneal Pharmaceuticals of New York LLC, sanctioning changes to …
-
FDA approval · 2019-08-27FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for metformin hydrochloride from Amneal Pharmaceuticals LLC, a generic formulation.
-
FDA approval · 2019-08-27FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Marlex Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Metformin Hydrochloride (generic) submitted by Marlex Pharmaceuticals, Inc., confirming/expa…
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: Effect of Whole-body Vibration on TcPO2 [Phase 3]
Phase 3 clinical trial investigating the effect of whole-body vibration on TcPO2 in patients with Type 2 diabetes mellitus, status currently…
-
FDA approval · 2019-08-22FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Foxiga Korea Local Phase 4 Study [Phase 4]
A Phase 4 study update for Foxiga in Korea has completed with posted results, involving Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial update for tirzepatide (LY3298176) in type 2 diabetes mellitus; trial completed with results posted.